Maynard Um
-
-
-
-
-
-
-
Protagonist and Takeda report 52-week rusfertide data in polycythemia vera
-
-
-
-
-
-
-
Cosmo and Takeda Renew Strategic Manufacturing Agreement for Global Supply of Oral Treatment for Ulcerative Colitis
-
-
-
-
-
-
-
Morgan Stanley Upgrades Takeda Pharmaceutical (4502:JP) (TAK) to Overweight
-
-
-
-
-
-
-
Takeda (TAK) Receives EU Approval for FRUZAQLA
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

